Athyrium Capital Management, LP - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAB7. A total of 14 filers reported holding PTC THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Athyrium Capital Management, LP ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q4 2018$8,071,000
-69.6%
8,067,000
-65.0%
7.78%
-63.4%
Q3 2018$26,578,000
-5.5%
23,067,000
-17.8%
21.23%
-30.2%
Q2 2018$28,135,000
-35.7%
28,067,000
-39.7%
30.42%
+13.5%
Q1 2018$43,752,000
+19.2%
46,567,000
+2.2%
26.79%
+23.4%
Q4 2017$36,690,00045,567,00021.70%
Other shareholders

There were no reported owners of PTC THERAPEUTICS INC in Q1 2019.

NameSharesValueWeighting ↓
View complete list of PTC THERAPEUTICS INC shareholders